The intersection of cancer and aging: Establishing the need for breast cancer rehabilitation

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 5, 2007, Pages 866-872

  Schmitz, Kathryn H ^a,b   Cappola, Anne R ^a   Stricker, Carrie T ^b,c   Sweeney, Carol ^d   Norman, Sandra A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; EXEMESTANE; HORMONE; LETROZOLE; TRASTUZUMAB;

AGING; BONE DENSITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER REHABILITATION; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; DAILY LIFE ACTIVITY; HEALTH CARE NEED; HEALTH PROGRAM; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONAL THERAPY; HUMAN; LUNG FUNCTION; MUSCLE ATROPHY; MUSCLE MASS; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL CAPACITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGING; BODY COMPOSITION; BREAST NEOPLASMS; DEPRESSION; HUMANS; PAIN; QUALITY OF LIFE; SURVIVORS;

EID: 34250367375     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0980     Document Type: Review

References (113)

1. From cancer patient to cancer survivor: lost in translation. Washington (DC): National Academy of Sciences; 2006.
2. Hewitt M, Rowland J, Yancik R. Cancer survivors in the united states: age, health, and disability. J Gerontol A Biol Med Sci 2003;58:82-91.
3. Institute NC. The NCI strategic plan for leading the nation to eliminate the suffering and death due to cancer. U S. Department of Health and Human Services/NIH; 2006.
4. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116:682-92.
5. Cancer facts and figures. Atlanta (GA); 2005.
6. Guralnik J, Fried L, Salive M. Disability as a public health outcome in the aging population. Annu Rev Public Health 1996;17:25-46.
7. Guralnik J, Winograd C. Physical performance measures in the assessment of older persons. Aging Clin Exp Res 1994;6:303-5.
8. Cress E, Buchner D, Questad K, Esselman P, deLateur B, Schwartz R. Continuous-scale physical functional performance in healthy older adults: a validation study. Arch Phys Med Rehabil 1996;77:1243-50.
9. Nagi SZ. An epidemiology of disability among adults in the united states. Milbank Mem Fund Q Health Soc 1976;54:439-67.
10. Verbrugge L, Jette A. The disablement process. Soc Sci Med 1994;38:1-14.
11. Sweeney C, Schmitz KH, Lazovich D, Virnig B, Wallace R, Folsom AR. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst 2006;98:521-9.
12. Ware JE, Snow KK, Kosinski MK, et al. Sf-36 health survey manual and interpretation guide. Boston (MA): Nimrod Press; 1993.
13. Ganz PA, Desmond KA, Leeham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94:39-49.
14. Yost K, Haan M, Levine R, Gold E. Comparing sf-36 scores across three groups of women with different health profiles. Qual Life Res 2005;14: 1251-61.
15. Vinokur A, Threatt B, Caplan R, Zimmerman B. Physical and psychosocial functioning and adjustment to breast cancer; long-term follow-up of a screening population. Cancer 1989;63:394-405.
16. Michael Y, Kawachi I, Berkman L, Holmes M, Colditz G. The persistent impact of breast carcinoma on functional health status: prospective evidence from the Nurses' Health Study. Cancer 2000;89:2176-86.
17. Guralnik J, Simonsick E, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-94.
18. Morley JE, Haren MT, Rolland Y, Kim MJ. Frailty. Med Clin North Am 2006; 90:837-47.
19. Magaziner J, Hawkes W, Hebel J, et al. Recovery from hip fracture in eight areas of function. J Gerontol Med Sci 2000;55A:M498-507.
20. Binder E, Brown M, Sinacore D, Steger-May K, Yarashesi K, Schechtman K. Effects of extended outpatient rehabilitation after hip fracture. JAMA 2004; 292:837-46.
21. Trojan D, Cashman N. Post-poliomyelitis syndrome. Muscle Nerve 2005;31: 6-19.
22. Stolwijk-Swuste JM, Beelen A, Lankhorst GJ, Nollet F. The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: a systematic review. Arch Phys Med Rehabil 2005;86: 1693-701.
23. Taylor CW, McGale P, Darby SC. Cardiac risks of breast-cancer radiotherapy: a contemporary view. Clin Oncol R Coll Radiol 2006;18:236-46.
24. Ganz P, Guadagnoli E, Landrum M, Lash T, Rakowski W, Silliman R. Breast cancer in older women: quality of life and psychological adjustment in the 15 months after diagnosis. J Clin Oncol 2003;21:4027-33.
25. Fehlauer F, Tribius S, Mehnert A, Rades D. Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy. Breast Cancer Res Treat 2005;92:217-22.
26. Vinokur A, Threatt B, Vinokur-Kaplan D, et al. The process of recovery from breast cancer for younger and older patients: changes during the first year. Cancer 1990;65:1242-54.
27. Wyatt G, Friedman L. Physical and psychosocial outcomes of midlife and older women following surgery and adjuvant therapy for breast cancer. Oncol Nurs Forum 1998;25:761-8.
28. Kroenke C, Rosner B, Chen W, Kawachi I, Colditz G, Holmes M. Functional impact of breast cancer by age at diagnosis. J Clin Oncol 2004;22:1849-56.
29. Ganz PA, Rowland JH, Desmond KA, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-14.
30. Ganz P, Greendale P, Petersen L, et al. Breast cancer in younger women: reproductive and late effects of treatment. J Clin Oncol 2003;21:4184-93.
31. Ahles T, Saykin A, Furstenberg C, et al. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard dose chemotherapy or local therapy. J Clin Oncol 2005;23:4399-405.
32. Ronka RH, Pamilo MS, von Smitten KA, Leidenius MH. Breast lymphedema after breast conserving treatment. Acta Oncol 2004;43:551-7.
33. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29:341-50.
34. Mortimer P. The prevalence of arm oedema following treatment for breast cancer. Q J Med 1996;89:377-80.
35. Reitman J, Dijkstra P, Hoekstra H, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systemic review. EJSO 2003;79:229-38.
36. Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998;16:1380-7.
37. Stricker C, Schuchter L. Patterns and predictors of functional status and symptom distress in older versus younger women undergoing adjuvant breast cancer chemotherapy. Abramson Cancer Center Annual Scientific Retreat, University of Pennsylvania; 2006.
38. Mols F, Vingerhoets A, Coebergh J, van de Poll-Franse L. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 2005;41:2613-9.
39. Samson M, Meeuwsen B, Crowe A, Dessens J, Duursma S, Verhaar H. Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 2000;29:235-42.
40. Going S, Williams D, Lohman T. Aging and body composition: biological changes and methodological issues. Exerc Sport Sci Rev 1995;23:411-58.
41. Iannuzzi-Sucich M, Prestwood K, Kenny A. Prevalence of sarcopenia and predictors of skeletal muscle mass in health, older men and women. J Gerontol Med Sci 2002;57A:M772-7.
42. Rantanen T, Guralnki J, Sakari-Rantala R, et al. Disability, physical activity, and muscle strength in older women: The Women's Health and Aging Study. Arch Phys Med Rehabil 1999;80:130-5.
43. Ferrucci L, Guralnik J, Studenski S, Fried L, Cutler G, Walston J. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older person: a consensus report. J Am Geriatr Soc 2004;52:625-34.
44. Janssen H, Samson M, Meeuwsen B, Duursma S, Verhaar H. Strength, mobility and falling in women referred to a geriatric outpatient clinic. Aging Clin Exp Res 2004;16:122-5.
45. Krebs D, Jette A, Assmann S. Moderate exercise improves gait stability in disabled elders. Arch Phys Med Rehabil 1998;79:1489-95.
46. Davis J, Ross P, Preston S, Nevitt M, Wasnich R. Strength, physical activity, and body mass index: relationship to performance-based measures and activities of daily living among older Japanese women in Hawaii. J Am Geriatr Soc 1998;46:274-9.
47. Sowers M, Crutchfield M, Richards K, et al. Sarcopenia is related to physical functioning and leg strength in middle-aged women. J Gerontol Med Sci 2005;60A:468-90.
48. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001;137:231-43.
49. Winningham ML, MacVicar MG, Bondoc M, Anderson JI, Minton JP. Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy. Oncol Nurs Forum 1989;16:683-9.
50. Cheney CL, Mahloch J, Freeny P. Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin 1997;66:141-6.
51. Demark-Wahnefried W, Peterson B, Winer E, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001; 19:2381-9.
52. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 1997;97:519-29.
53. Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 1993;11:1418-29.
54. Rietman J, Dijkstra P, Hoekstra H, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. EJSO 2003;29:229-38.
55. Hayes S, Battistutta D, Newman B. Objective and subjective upper body function six months following diagnosis of breast cancer. Cancer Res Treat 2005;94:1-10.
56. Bower J, Ganz P, Aziz N, Fahey J. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002;64:604-11.
57. Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-802.
58. Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081-92.
59. Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, tamoxifen alone or in combination) trial efficacy and safety update analyses. Cancer 2003;98:1802-10.
60. Perez EA, Josse RG, Pritchard KI, et al. Effect of letrozole versus placebo on bone mineral density in women completing >5 years of adjuvant tamoxifen: NCIC CTG MA-17b. 27th Annual San Antonio Breast Cancer Symposium. San Antonio (TX): Breast Cancer Research and Treatment; 2004. p. 88.
61. Coleman R, Banks R, Hall E, et al. Intergroup exemestane study: 1 year results of the bone subprotocol. (27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX). Breast Cancer Res Treat 2004;88:S35.
62. Goodwin P, Ennis M, Pritchard K, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999;17: 2365-70.
63. Cappola A, Xue Q, Ferrucci L, Guralnik J, Volpato S, Fried L. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003;88:2019-25.
64. Taaffe D, Harris T, Ferrucci L, Rowe J, Seeman T. Cross-sectional and prospective relationships of interleukin-6 and c-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol Med Sci 2000;55A:M709-15.
65. Ferrucci L, Penninx B, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002;50:1947-54.
66. Cesari M, Penninx B, Pahor M, et al. Inflammatory markers and physical performance in older persons: The Inchianti Study. J Gerontol Med Sci 2004; 59A:242-8.
67. Pusztai L, Mendoza T, Reuben J, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 2004;25:94-102.
68. Frassica D, Bajaj G, Tsangaris T. Treatment of complications after breast-conservation therapy. Oncology 2003;17:1118-28.
69. Janssens J. Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion. Clin Chest Med 2005;26:469-84.
70. Zeleznik J. Normative aging of the respiratory system. Clin Geriatr Med 2003;19:1-18.
71. Lakatta E, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I. Aging arteries: a "set up" for vascular disease. Circulation 2003;107:139-46.
72. Lakatta E, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003;107:346-54.
73. US Department of Health and Human Services. Physical activity and health: a report of the surgeon general. Atlanta (GA): National Center for Chronic Disease Prevention and Health Promotion; 1996.
74. Simpson C, Punjabi N, Wolfenden L, Shardell M, Shade D, Fried L. Relationship between lung function and physical performance in disabled older women. J Gerontol Med Sci 2005;60A:330-54.
75. Cook N, Albert M, Berkman L, Blazer D, Taylor J, Hennekens C. Interrelationships of peak expiratory flow rate with physical and cognitive function in the elderly: MacArthur foundation studies of aging. J Gerontol Med Sci 1995;50A:M317-23.
76. Strawbridge W, Cohen R, Sherma S, Kaplan G. Successful aging: predictors and associated activities. Am J Epidemiolo 1996;144:135-41.
77. Rozzini R, Frisoni G, Ferruci L, Barbisoni P, Bertozzi B, Trabucchi M. The effect of chronic diseases on physical function. Comparison between activities of daily living scales and the physical performance test. Age Ageing 1997;26:281-7.
78. Shumway-Cook A, Ciol M, Yorkston K, Hoffman J, Chan L. Mobility limitations in the medicare population: prevalence and sociodemographic and clinical correlates. J Am Geriatr Soc 2005;53:1217-21.
79. Richardson J. Gender differences associated with physical functioning in older persons with angina. Disabil Rehabil 2003;25:973-83.
80. Lind P, Wennberg B, Gagliardi G, et al. Roc curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. Int J Radiat Oncol Biol Phys 2006;64:765-70.
81. Tokatli F, Kaya M, Kocak Z, et al. Sequential pulmonary effects of radiotherapy detected by functional and radiological end points in women with breast cancer. Clin Oncol (R Coll Radiol) 2005;17:39-46.
82. Ooi G, Kwong D, Ho J, et al. Pulmonary sequelae of treatment for breast cancer: a prospective study. Int J Radiat Oncol Biol Phys 2001;50: 411-9.
83. Jung B, Ahrendt G, Oaklander A, Dworkin R. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 2003;104:1-13.
84. Mantini G, Smaniotto D, Balducci M, et al. Radiation-induced cardiovascular disease: impact of dose and volume. Rays 2005;30:157-68.
85. Gyenes G, Fornander T, Carlens P, Rutqvist L. Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:1235-41.
86. Taghian A, Assaad S, Niemierko A, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001;93:1806-11.
87. Theuws J, Muller S, Seppenwoodle Y, et al. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: a follow-up study. J Clin Oncol 1999;17:3091-100.
88. Ng R, Better N, Green M. Anticancer agents and cardiotoxicity. Semin Oncol 2006;33:2-14.
89. Willems A, Gauger K, Henrichs C, Harbeck N. Antibody therapy for breast cancer. Anticancer Res 2005;25:1483-9.
90. Romond E, Perez E, Bryant J, et al. Trasruzumab plus adjuvant chemotherapy for operable her2-positive breast cancer. N Engl J Med 2005;353:167384.
91. Tan-Chiu E, Yothers G, Romond E, et al. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: Nsabp-31. J Clin Oncol 2005;23:7811-9.
92. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 2001;344:1997-2008.
93. Tannock C, Katona C. Minor depression in the aged. Concepts, prevalence and optimal management. Drugs Aging 1995;6:278-92.
94. Peters R. Ageing and the brain. Postgrad Med J 2006;82:84-8.
95. Leveille S, Fried L, McMullen W, Guralnik J. Advancing the taxonomy of disability in older adults. J Gerontol Med Sci 2004;59A:86-93.
96. Reuben D, Siu A. An objective measure of physical function of elderly outpatients: the physical performance test. J Am Geriatr Soc 1990;38:1105-12.
97. Liu-Ambrose T, Eng J, Khan K, Mallinson A, Carter N, McKay H. The influence of back pain on balance and functional mobility in 65- to 75-year-old women with osteoporosis. Osteoporos Int 2002;13:868-73.
98. Savard J, Marin C. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001;19:895-908.
99. Helgeson V, Romich P. Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology 2005;14: 307-17.
100. Williamson G. Extending the activity restriction model of depressed effect: evidence from a sample of breast cancer patients. Health Psychol 2000;19: 339-47.
101. Rugo HS, Ahles T. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Semin Oncol 2003;30:749-62.
102. Malmstrom T, Wolinsky F, Andresen E, Miller J, Miller D. Cognitive ability and physical performance in middle-aged African Americans. J Am Geriatr Soc 2005;53:997-1001.
103. Royall D, Palmer R, Chiodo L, Polk M. Declining executive control in normal aging predicts change in functional status: the freedom house study. J Am Geriatr Soc 2004;52:346-52.
104. Newman A, Haggerty C, Kritchevsky S, Nevitt M, Simonsick E. Walking performance and cardiovascular response: associations with age and morbidity - the health, aging and body composition study. J Gerontol Med Sci 2003;58A:715-20.
105. Macera CA, Ham SA, Yore MM, et al. Prevalence of physical activity in the united states: behavioral risk factor surveillance system, 2001 [serial online]. Prev Chronic Dis 2005;2:1-10.
106. Irwin ML, Crumley D, McTiernan A, et al. Physical activity levels before and after a diagnosis of breast carcinoma: the health, eating, activity, and lifestyle (heal) study. Cancer 2003;97:1746-57.
107. Schmitz K, Holtzman J, Courneya K, Masse L, Duval S, Kane R. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2005;14:1588-95.
108. Chen SC, Chen MF. Timing of shoulder exercise after modified radical mastectomy: a prospective study. Changgeng Yi Xue Za Zhi 1999;22:37-43.
109. McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol 2003;21: 463-6.
110. Turner J, Hayes S, Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol 2004;86:141-6.
111. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 2006;24:2765-72.
112. Brach J, VanSwearingen J, Newman A, Kriska A. Identifying early decline of physical function in community-dwelling older women: performance-based and self-report measures. Phys Ther 2002;82:320-8.
113. Fried L, Young Y, Rubin G, Bandeen-Roche K. Self-reported preclinical disability identifies older women with early declines in performance and early disease. J Clin Epidemiol 2001;54:889-901.